What is the recommended fish‑oil (EPA/DHA) dosage for reducing elevated triglyceride levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Fish Oil Dose for Triglycerides

For elevated triglycerides, use prescription omega-3 fatty acids at 4 grams per day of EPA+DHA (or EPA alone), which reduces triglycerides by 25-30% in moderate hypertriglyceridemia and up to 45% in severe cases. 1, 2, 3

Dosing Algorithm Based on Triglyceride Level

For Triglycerides 200-499 mg/dL (Moderate Hypertriglyceridemia)

  • Prescription omega-3 fatty acids: 4 g/day of total EPA+DHA 1, 3
  • This achieves approximately 25-30% triglyceride reduction 2, 3
  • Can be used as monotherapy or combined with statins 3

For Triglycerides ≥500 mg/dL (Severe Hypertriglyceridemia)

  • Prescription omega-3 fatty acids: 4 g/day of EPA+DHA 1, 2
  • Achieves 45% or greater triglyceride reduction 4
  • Primary goal is preventing acute pancreatitis 5
  • Must be used under physician supervision 2, 4

Dose-Response Relationship

The evidence demonstrates a clear dose-response pattern:

  • Each 1 gram of EPA/DHA reduces triglycerides by approximately 5-10% 2
  • Doses below 2 g/day show minimal efficacy 6
  • Optimal triglyceride-lowering occurs at 3-4 g/day 6
  • Doses of 200-500 mg/day (dietary amounts) produce only 3-7% reductions 6

Critical Distinction: EPA vs EPA+DHA Combinations

Recent evidence reveals important differences between formulations:

EPA-only (icosapent ethyl) at 4 g/day:

  • Does not raise LDL-C in patients with very high triglycerides 1
  • Demonstrated 25% cardiovascular event reduction in REDUCE-IT trial 3, 5
  • Preferred for high-risk patients already on statins 5, 7

EPA+DHA combinations at 4 g/day:

  • May increase LDL-C by 5-10%, particularly when baseline triglycerides are very high 2, 4
  • Equally effective for triglyceride lowering as EPA-only 3
  • When used with statins or as monotherapy for moderate hypertriglyceridemia, does not raise LDL-C 3

Important Caveats

Low-dose EPA+DHA (≤1 g/day) is ineffective: Multiple large trials (ASCEND, VITAL, OMEMI) using 840-1800 mg/day showed no cardiovascular benefit or triglyceride reduction when baseline triglycerides were not elevated 1, 5. These doses should not be used for triglyceride management.

Over-the-counter fish oil supplements: While available without prescription, the American Heart Association advises that triglyceride-lowering therapy with EPA/DHA should only be used under physician supervision to ensure consistent quality, purity, and appropriate dosing 2, 4.

Baseline triglyceride level matters: Patients with higher baseline triglycerides experience greater absolute reductions—the response is curvilinear, with 30% reduction at higher baselines versus 20% at lower levels 2.

Practical Implementation

For prescription omega-3 therapy:

  • Standard dose: 4 capsules daily (each 1-g capsule contains 840 mg EPA+DHA) 1, 3
  • Can be taken as single dose or divided 4
  • Well-tolerated with low discontinuation rates 4
  • Monitor LDL-C levels, particularly in patients with very high triglycerides receiving EPA+DHA formulations 2, 4

The net effect of 4 g/day therapy is reduction in non-HDL cholesterol and apolipoprotein B, indicating overall reduction in atherogenic lipoproteins despite potential modest LDL-C increases with some formulations 3.

Related Questions

What is the recommended omega‑3 dosage for a 22‑year‑old male with hypertriglyceridemia?
What is the recommended omega-3 (fatty acid) dosage for hypertriglyceridemia (elevated triglycerides) with levels exceeding 500 milligrams per deciliter (mg/dL)?
What is the recommended omega‑3 fatty acid (eicosapentaenoic acid and docosahexaenoic acid) dose and monitoring strategy for a patient with hypertriglyceridemia?
What is the maximum dosage of omega‑3 fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) for treating uncontrolled hypertriglyceridemia?
What is the optimal omega‑3 (EPA/DHA) dosing and lifestyle plan for hypertriglyceridemia, and when should a fibrate be added if triglycerides remain >500 mg/dL after 8–12 weeks?
Why is captopril administered as a STAT (immediate) dose?
What is the appropriate evaluation and management for a 35-year-old Black female with a white blood cell count of 3.3 ×10⁹/L, red blood cell count of 5.25 ×10¹²/L, hemoglobin 12.4 g/dL, hematocrit 39 %, mean corpuscular volume 74.3 fL, mean corpuscular hemoglobin 23.6 pg, red cell distribution width 15.1 %, absolute monocyte count 198 cells/µL, and eosinophil count 10 cells/µL?
In a 35‑year‑old Black female with microcytic anemia (mean corpuscular volume 74.3 fL, red cell distribution width 15.1 %), what does an iron level of 70 µg/dL and ferritin of 71 ng/mL indicate and what is the appropriate next diagnostic step?
What daily dose of fish oil (eicosapentaenoic acid + docosahexaenoic acid) is recommended for an adult without known cardiovascular disease seeking general cardiovascular health, and what contraindications should be considered?
In a man with hemoglobin 16.4 g/dL, hematocrit 49%, normal platelet count, normal mean corpuscular volume, and spleen size 13.5 cm, what is the appropriate workup and management?
How should I manage a 32-year-old male presenting with myalgias, serum albumin 5.2 g/dL, leukocytosis (WBC 12.7 ×10⁹/L), and neutrophilia (absolute neutrophil count 10,668/µL)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.